# Hikma Pharmaceuticals (Hikma Pharmaceuticals Public Limited Company)

Public limited company registered in London, classed under “Manufacture of basic pharmaceutical products”.

- Company number: 05557934
- Status: Active
- Type: Public limited company
- Incorporated: 8 September 2005
- Registered office: 10 Portman Square, London, W1H 6AZ
- Location: London
- Activity: Manufacture of basic pharmaceutical products
- Website: hikma.com

## Latest filed profit

Profit after tax in the year to 31 December 2025: **$407m**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Hikma Pharmaceuticals do?

Public limited company registered in London, classed under “Manufacture of basic pharmaceutical products”. In its own words: “Hikma is a leading global pharmaceutical company that manufactures high-quality generic medicines and makes them accessible to people who need them.”

### How much turnover does Hikma Pharmaceuticals make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/hikma-pharmaceuticals-05557934

### Is Hikma Pharmaceuticals profitable?

Yes: it made a profit after tax of $407m in the year to 31 December 2025, its latest filed accounts.

### Who runs and owns Hikma Pharmaceuticals?

Its directors are Helen Middlemist, Ali Mohammed Al Husry, Laura Mihaela Balan, Said Samih Darwazah, Mazen Samih Darwazeh and 6 more. Its owners are shown to subscribers.

### Where is Hikma Pharmaceuticals based?

Its registered office is 10 Portman Square, London, W1H 6AZ, in London.

### When was Hikma Pharmaceuticals founded?

Hikma Pharmaceuticals Public Limited Company was incorporated on 8 September 2005.

### Is Hikma Pharmaceuticals still trading?

The register lists Hikma Pharmaceuticals Public Limited Company as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-10-12: Cancellation of shares. Statement of capital on 25 August 2026 · GBP 22,162,866.00 (and 32 more like it since 28 April 2026)
- 2026-10-06: Purchase of own shares (and 25 more like it since 8 April 2026)
- 2026-08-13: Director's details changed for Mazen Samih Darwazah on 8 September 2005
- 2026-08-12: Appointment of Mr Tobias Hannes Hestler as a director on 7 August 2026
- 2026-07-29: Registered office address changed from 10 Portman Square 10 Portman Square London W1H 6AZ England to 10 Portman Square London W1H 6AZ on 29 July 2026
- 2026-07-20: Director's details changed for Ms Victoria Mary Hull on 17 July 2026
- 2026-06-26: Director's details changed for Dr Deneen Vojta on 18 May 2026 (and 1 more like it since 19 May 2026)
- 2026-05-20: Director's details changed for Ms Victoria Mary Hull on 18 May 2026
- 2026-05-20: Director's details changed for Ms Laura Mihaela Balan on 18 May 2026
- 2026-05-19: Director's details changed for Mr Douglas Malcolm Hurt on 18 May 2026
- 2026-05-19: Secretary's details changed for Mrs Helen Middlemist on 18 May 2026
- 2026-05-18: Registered office address changed from 1 New Burlington Place London W1S 2HR United Kingdom to 10 Portman Square 10 Portman Square London W1H 6AZ on 18 May 2026
- 2026-05-13: Resolutions (and 2 more like it since 2 May 2024)
- 2026-05-04: Group of companies' accounts made up to 31 December 2025
- 2026-03-25: Director's details changed for Ms Victoria Mary Hull on 30 June 2025
- 2026-01-06: Termination of appointment of Mary Regina Henderson as a director on 31 December 2025
- 2025-12-27: Appointment of Mr Khalid Walid Hussni Nabilsi as a director on 15 December 2025
- 2025-12-15: Termination of appointment of Riad Ali Mishlawi as a director on 15 December 2025
- 2025-09-03: Register inspection address has been changed
- 2025-04-30: Group of companies' accounts made up to 31 December 2024
- 2025-04-28: Termination of appointment of John Julius Castellani as a director on 24 April 2025
- 2024-07-01: Statement of capital following an allotment of shares on 10 June 2024 · GBP 23,471,968.6 (and 6 more like it since 4 September 2023)
- 2024-05-04: Group of companies' accounts made up to 31 December 2023
- 2024-02-29: Termination of appointment of Patrick Noel Butler as a director on 29 February 2024
- 2024-02-08: Director's details changed for Ms Victoria Hull on 7 February 2024

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/hikma-pharmaceuticals-05557934